TPCW
TEVA icon

TD Private Client Wealth’s Teva Pharmaceuticals TEVA Stock Holding History

TD Private Client Wealth’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.8K Sell
1,529
-207
-12% -$6.89K ﹤0.01% 881
2026
Q1 		$52.3K Buy
1,736
+1,690
+3,674% +$54.4K ﹤0.01% 867
2025
Q4 		$1.44K Buy
46
+10
+28% +$246 ﹤0.01% 1316
2025
Q3 		$727 Hold
36
– – ﹤0.01% 1390
2025
Q2 		$603 Sell
36
-34
-49% -$549 ﹤0.01% 1339
2025
Q1 		$1.08K Sell
70
-8
-10% -$143 ﹤0.01% 1282
2024
Q4 		$1.72K Buy
78
+4
+5% +$73 ﹤0.01% 1208
2024
Q3 		$1.33K Sell
74
-93
-56% -$1.63K ﹤0.01% 1217
2024
Q2 		$2.71K Buy
167
+133
+391% +$2.05K ﹤0.01% 1121
2024
Q1 		$480 Hold
34
– – ﹤0.01% 1201
2023
Q4 		$355 Buy
+34
New +$317 ﹤0.01% 1206
2023
Q2 		– Sell
-27
Closed -$239 – 1282
2023
Q1 		$239 Hold
27
– – ﹤0.01% 1236
2022
Q4 		$246 Hold
27
– – ﹤0.01% 1202
2022
Q3 		$218 Sell
27
-11
-29% -$97 ﹤0.01% 1207
2022
Q2 		$286 Hold
38
– – ﹤0.01% 1214
2022
Q1 		$357 Hold
38
– – ﹤0.01% 1250
2021
Q4 		$304 Sell
38
-11,428
-100% -$103K ﹤0.01% 1151
2021
Q3 		$112K Buy
11,466
+11,428
+30,074% +$107K ﹤0.01% 616
2021
Q2 		$376 Hold
38
– – ﹤0.01% 1201
2021
Q1 		$439 Hold
38
– – ﹤0.01% 1135
2020
Q4 		$367 Hold
38
– – ﹤0.01% 1107
2020
Q3 		$342 Buy
38
+13
+52% +$138 ﹤0.01% 1068
2020
Q2 		$308 Hold
25
– – ﹤0.01% 1065
2020
Q1 		$225 Buy
+25
New +$256 ﹤0.01% 1041

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

TD Private Client Wealth's TEVA Position: Q2 2026 in Review

TD Private Client Wealth reduced its Teva Pharmaceuticals (TEVA) stake by 12% in Q2 2026, selling an estimated $6.89K and leaving 1,529 shares worth $51.8K. The position accounts for ﹤0.01% of the portfolio, ranked #881.

TD Private Client Wealth first reported a position in TEVA in Q1 2020 and has held it in 24 quarters since. The position peaked at $112K in Q3 2021. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • TD Private Client Wealth held 1,529 shares of Teva Pharmaceuticals worth $51.8K as of Q2 2026.
  • TD Private Client Wealth sold 207 Teva Pharmaceuticals shares in Q2 2026, an estimated $6.89K.
  • Teva Pharmaceuticals made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #881 holding.
  • TD Private Client Wealth first reported a position in Teva Pharmaceuticals in Q1 2020 and has held it in 24 quarters since.
  • TD Private Client Wealth's Teva Pharmaceuticals position peaked at $112K in Q3 2021.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.